ASTEC

Astec LifeSciences Limited

Source: NSE · Updated 4 Nov, 11:32 pm IST

Filed 26 Oct, 07:24 pm IST Q2 FY27 (Sep ’26)Consolidated₹ lakhs

Revenue

7,202.01

▼ 2.3% vs Q2 FY26

Operating profit (EBITDA, derived from filing)

-1,979.21

vs Q2 FY26: n/a

Net profit

-3,739.71

vs Q2 FY26: n/a

EPS (₹)

-16.79

vs Q2 FY26: n/a

Operating margin

-27.5%

−1840 bps vs Q2 FY26

Net margin

-51.9%

−1880 bps vs Q2 FY26

Loss widened vs Q2 FY26

Revenue−2% vs Q2 FY26 · −14% vs Q1 FY27

ProfitLoss widened vs Q2 FY26 · Loss widened vs Q1 FY27

View official filing ↗

Numbers from the company's structured XBRL filing on NSE, cross-checked with P&L totals.

Previous-quarter and year-ago figures: as originally reported in those quarters' NSE filings; filing PDF not available to confirm restatements.

Quarter comparison

Item	Q2 FY27 (Sep ’26)	Q1 FY27 (Jun ’26)	vs Q1 FY27	Q2 FY26 (Sep ’25)	vs Q2 FY26
Revenue from operations	7,202.01	8,356.43	▼ 13.8%	7,372.06	▼ 2.3%
Other income	61.63	72.74	▼ 15.3%	111.56	▼ 44.8%
Total income	7,263.64	8,429.17	▼ 13.8%	7,483.62	▼ 2.9%
Total expenses	11,006.42	10,302.99	▲ 6.8%	9,924.36	▲ 10.9%
Operating profit (EBITDA)*	-1,979.21	-66.61	—	-668.68	—
Profit before tax	-3,742.78	-1,873.82	—	-2,440.74	—
Tax expense	-3.07	-3.09	—	0.96	—
Net profit	-3,739.71	-1,870.73	—	-2,441.7	—
EPS (₹)	-16.79	-8.40	—	-11.35	—
Operating margin	-27.5%	-0.8%	−2670 bps	-9.1%	−1840 bps
Net margin	-51.9%	-22.4%	−2950 bps	-33.1%	−1880 bps

Showing Q2 FY27 (Sep ’26) and change vs Q2 FY26. Turn your phone sideways for Q1 FY27 (Jun ’26).

Figures in ₹ lakhs except EPS. Consolidated figures from the company's XBRL filing on NSE. Each row is shown only if it reconciles with the others (e.g. PBT − tax = net profit); rows we couldn't verify are left out. Net margin = net profit ÷ revenue. *Operating profit (EBITDA), derived from the filing: profit before exceptional items and tax + finance costs + depreciation − other income. Operating margin = EBITDA ÷ revenue.

All Astec LifeSciences results, dividends & filings ›

Other results filed 26 Oct

NAZARA Nazara Technologies Limited›LEAPIND LEAP India Limited›PAYTM One 97 Communications Limited›SURANASOL Surana Solar Limited›WEWORK WeWork India Management Limited›DEEPA Deepa Jewellers Limited›SUNTECK Sunteck Realty Limited›SMCGLOBAL SMC Global Securities Limited›AEQUS Aequs Limited›PARACABLES Paramount Communications Limited›JBMA JBM Auto Limited›MANKIND Mankind Pharma Limited›

Today's results ›

ASTEC LIFESCIENCES Q2 FY27 ; NET LOSS OF ₹37 CR VS LOSS ₹24 CR (YOY), LOSS ₹19 CR (QOQ)

REVENUE DOWN 2% AT ₹72 CR (YOY), DOWN 14% (QOQ)

EBITDA LOSS OF ₹20 CR VS LOSS ₹6.69 CR (YOY), LOSS ₹0.67 CR (QOQ)

MARGINS AT -27.5% VS -9.1% (YOY), -0.8% (QOQ)

https://resultkal.com/r/astec-2026-10-26
Source: NSE filing · not investment advice

FAQ

When did Astec LifeSciences announce Q2 FY27 results?

Astec LifeSciences filed its results on NSE on 26 Oct, 07:24 pm IST.

What does QoQ and YoY mean?

QoQ compares with the previous quarter; YoY compares with the same quarter last year. Growth is calculated from the figures in the filing.

Are these Astec LifeSciences figures official?

They are auto-read from the company's NSE filing and may contain errors. Always confirm with the official PDF linked on this page.

Explore

Today's results Results this week Q2 FY27 results dates Dividend stocks this week Bonus issue 2026 Stock split 2026

Figures are auto-read from the company's NSE filing and may contain errors. Check the official filing before deciding. Not investment advice.

← ASTEC overview